Dewpoint Therapeutics, a US biotech focused on the application of biomolecular condensate biology, has announced the ...

Orally administered small molecule condensate modulators (c-mods) are a novel class of therapeutic agents designed to target condensates to ...

THRAP3, STMN1, and GNA13—are overrepresented in blood cancers like acute myeloid leukemia (AML) and could prove to be novel ...

1 The First Affiliated Hospital (The First School of Clinical Medicine), Guangdong Pharmaceutical University, Guangzhou, China 2 Guangdong Metabolic Diseases Research Center of Integrated Chinese and ...

Ewha Womans University Seoul Hospital, Seoul, Korea, Republic of.

Treating root causal genes can modify disease pathogenesis in its entirety, whereas targeting other causes may only provide symptomatic relief. For example, mutations in Gaucher disease cause ...

Patients with a mutation in the beta-catenin gene had an increased objective response rate, and a longer median OS was observed in the updated data set. Both were supported by amezalpat’s ...

The vast majority of human genes -- more than nine in ten -- are edited by the spliceosome. The sheer number of ...

4 release. TCGFB is paying Surrozen up to $6 million, plus any third-party costs, for antibodies that target transforming growth factor beta (TGF-Beta). Dysfunctional TGF-Beta is a major ...

The iOS 18.1 RC public beta is the last beta release before the general public version releases next week, bringing Apple Intelligence to the iPhone. Nelson Aguilar is an LA-based tech how-to ...